Predicting Response to Standardized Pediatric Colitis Therapy

Summary

Predicting Response to Standardized Pediatric Colitis Therapy is a clinical trial^[1].

Key Facts

• Predicting Response to Standardized Pediatric Colitis Therapy is in the country of Canada^[2].
• Predicting Response to Standardized Pediatric Colitis Therapy is in the country of United States^[3].
• Predicting Response to Standardized Pediatric Colitis Therapy's instance of is recorded as clinical trial^[4].
• Predicting Response to Standardized Pediatric Colitis Therapy's start time is recorded as +2012-05-01T00:00:00Z^[5].
• Predicting Response to Standardized Pediatric Colitis Therapy's end time is recorded as +2018-04-30T00:00:00Z^[6].
• Predicting Response to Standardized Pediatric Colitis Therapy's main subject is recorded as ulcerative colitis^[7].
• Predicting Response to Standardized Pediatric Colitis Therapy's main subject is recorded as colitis^[8].
• Predicting Response to Standardized Pediatric Colitis Therapy's number of participants is recorded as {'unit': '1', 'amount': '+467'}^[9].
• Predicting Response to Standardized Pediatric Colitis Therapy's title is recorded as Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.^[10].
• Predicting Response to Standardized Pediatric Colitis Therapy's short name is recorded as PROTECT^[11].
• Predicting Response to Standardized Pediatric Colitis Therapy's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+4'}^[12].
• Predicting Response to Standardized Pediatric Colitis Therapy's ClinicalTrials.gov ID is recorded as NCT01536535^[13].
• Predicting Response to Standardized Pediatric Colitis Therapy's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+17'}^[14].
• Predicting Response to Standardized Pediatric Colitis Therapy's research intervention is recorded as prednisone^[15].
• Predicting Response to Standardized Pediatric Colitis Therapy's research intervention is recorded as mesalazine^[16].
• Predicting Response to Standardized Pediatric Colitis Therapy's clinical trial phase is recorded as phase IV clinical trial^[17].
• Predicting Response to Standardized Pediatric Colitis Therapy's research site is recorded as University of California, San Francisco^[18].
• Predicting Response to Standardized Pediatric Colitis Therapy's research site is recorded as Connecticut Children's Medical Center^[19].
• Predicting Response to Standardized Pediatric Colitis Therapy's research site is recorded as University of North Carolina at Chapel Hill^[20].
• Predicting Response to Standardized Pediatric Colitis Therapy's research site is recorded as Cincinnati Children's Hospital Medical Center^[21].
• Predicting Response to Standardized Pediatric Colitis Therapy's research site is recorded as Vanderbilt University^[22].
• Predicting Response to Standardized Pediatric Colitis Therapy's research site is recorded as University of Pittsburgh^[23].
• Predicting Response to Standardized Pediatric Colitis Therapy's research site is recorded as IWK Health Centre^[24].
• Predicting Response to Standardized Pediatric Colitis Therapy's research site is recorded as Medical College of Wisconsin^[25].
• Predicting Response to Standardized Pediatric Colitis Therapy's research site is recorded as Nemours Children's Clinic^[26].